Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Zeiser

Showing results (261-270 of 334) with videos related to

Pageof 34
Sort By:
American Journal of Hematology|August 29, 2025
Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMTJuan Carlos Hernández-Boluda, Vipul Sheth, Simona Iacobelli, et al.
Science Translational Medicine|December 21, 2022
Human β-defensin 2 ameliorates acute GVHD by limiting ileal neutrophil infiltration and restraining T cell receptor signalingTamina Rückert, Geoffroy Andrieux, Melanie Boerries, et al.
Immunity|July 21, 2021
β<sub>2</sub>-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progressionDaniel Hofbauer, Dimitrios Mougiakakos, Luca Broggini, et al.
The Lancet. Haematology|February 1, 2020
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Tapani Ruutu, et al.
Science Translational Medicine|October 29, 2020
Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humansFranziska M Uhl, Sophia Chen, David O'Sullivan, et al.
Nature Immunology|February 15, 2024
IL-23 stabilizes an effector T<sub>reg</sub> cell program in the tumor microenvironmentTobias Wertheimer, Pascale Zwicky, Lukas Rindlisbacher, et al.
Blood|February 4, 2016
Caveolin-1 regulates TCR signal strength and regulatory T-cell differentiation into alloreactive T cellsAnne Schönle, Frederike A Hartl, Jan Mentzel, et al.
JCI Insight|October 4, 2019
Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethalityAsim Saha, Patricia A Taylor, Christopher J Lees, et al.
Bone Marrow Transplantation|July 2, 2026
A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemiaAlexandros Spyridonidis, Allain Thibeault Ferhat, Jacques Emmanuel Galimard, et al.
Oncotarget|May 6, 2017
Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-β1 expressionHana Andrlová, Justin Mastroianni, Josef Madl, et al.
Pageof 34

Showing results (261-270 of 334) with videos related to

Sort By:
Pageof 34
American Journal of Hematology|August 29, 2025
Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMTJuan Carlos Hernández-Boluda, Vipul Sheth, Simona Iacobelli, et al.
Science Translational Medicine|December 21, 2022
Human β-defensin 2 ameliorates acute GVHD by limiting ileal neutrophil infiltration and restraining T cell receptor signalingTamina Rückert, Geoffroy Andrieux, Melanie Boerries, et al.
Immunity|July 21, 2021
β<sub>2</sub>-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progressionDaniel Hofbauer, Dimitrios Mougiakakos, Luca Broggini, et al.
The Lancet. Haematology|February 1, 2020
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Tapani Ruutu, et al.
Science Translational Medicine|October 29, 2020
Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humansFranziska M Uhl, Sophia Chen, David O'Sullivan, et al.
Nature Immunology|February 15, 2024
IL-23 stabilizes an effector T<sub>reg</sub> cell program in the tumor microenvironmentTobias Wertheimer, Pascale Zwicky, Lukas Rindlisbacher, et al.
Blood|February 4, 2016
Caveolin-1 regulates TCR signal strength and regulatory T-cell differentiation into alloreactive T cellsAnne Schönle, Frederike A Hartl, Jan Mentzel, et al.
JCI Insight|October 4, 2019
Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethalityAsim Saha, Patricia A Taylor, Christopher J Lees, et al.
Bone Marrow Transplantation|July 2, 2026
A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemiaAlexandros Spyridonidis, Allain Thibeault Ferhat, Jacques Emmanuel Galimard, et al.
Oncotarget|May 6, 2017
Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-β1 expressionHana Andrlová, Justin Mastroianni, Josef Madl, et al.
Pageof 34